This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Philips Introduces Breakthrough Graphical Dashboard To Advance Its EICU Telehealth Offering

NEW ORLEANS, March 4, 2013 /PRNewswire/ -- Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today announces the launch of its IntelliSpace eCareManager 3.9 health care platform, powered by orb, during the Healthcare Information and Management Systems Society (HIMSS) 2013 conference and exhibition. Included in Philips' latest offering to its eICU program is orb, a new graphical dashboard that is actuated by over 100 clinical rules, to analyze, process and visualize complex clinical data in real time and tell a better story about what is going on with that specific patient, and in a visually digestible form.

To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/philips-introduces-breakthrough-graphical-dashboard-to-advance-its-eicu-telehealth-offering-194402511.html

Currently, Philips eICU customers have oversight for nearly 7,000 ICU beds, with approximately 150 patients being monitored in an average Tele-ICU simultaneously, with larger sites caring for over 400 patients on any given day. To present data to support proactive patient interaction, a new type of population-based representation is needed.

Orb's ability to integrate practical data with visual technology helps clinicians to prioritize patient needs and streamline in-hospital care. The dashboard features circles that represent individual patients and their health status. By viewing these circles, clinicians can determine, at a glance, important patient or population-level information, such as which patients are in need of immediate care versus others who might be ready for hospital discharge. It also helps clinicians prioritize information that was previously unavailable due to the massive amount of data created by a single patient, whether they are providing care at the bedside, from the nurses' station, or hundreds of miles away from a remote, centralized telehealth care team.

"Health reform places priority on improving the quality of patient care, and key performance indicators such as patient mortality, length of stay, hospital-acquired infections, and hospital readmissions across health system enterprises," said Lori Lazzara, vice president and general manager, Connected Care Solutions, Philips Healthcare. "Philips eICU Program customers monitor more than 350,000 ICU patients every year and orb demonstrates our commitment to connected care, giving clinicians the flexibility to manage a large population of patients without losing the individualized treatment needs of each person."

Hospital systems participating in peer-reviewed studies on Tele-ICU programs have shown a reduction in mortality of 20% and length of stay by 30%,[1,2,3] and cost reductions in one of the highest cost areas for any hospital. Showcasing its commitment in this space, the Philips eICU program solution seamlessly blends medicine, transformative services and technology to address ICU physician and nurse shortages, increase access to care and dramatically improve quality of care. The Philips eICU program has been shown to reduce mortality and LOS at those levels.[1,2]

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,079.57 -42.44 -0.25%
S&P 500 1,996.74 -3.38 -0.17%
NASDAQ 4,557.6950 -11.9260 -0.26%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs